When was Asahi Kasei Corporate Venture Capital founded?

Asahi Kasei Corporate Venture Capital was founded in 2008.

Where is Asahi Kasei Corporate Venture Capital headquartered?

Asahi Kasei Corporate Venture Capital is headquartered in Menlo Park, CA.

How many investments has Asahi Kasei Corporate Venture Capital made?

Asahi Kasei Corporate Venture Capital has made 74 investments.

What has Asahi Kasei Corporate Venture Capital invested in?

Asahi Kasei Corporate Venture Capital has made numerous investments in companies like Glycomine , Power to Hydrogen , and Kins (Clinics/Outpatient Services) within the Drug Discovery, Energy Production, and Clinics/Outpatient Services industries.

What has Asahi Kasei Corporate Venture Capital invested in recently?

Asahi Kasei Corporate Venture Capital's latest investment was on 16-Apr-2025 in Glycomine , a company within the Drug Discovery industry.

Asahi Kasei Corporate Venture Capital investment portfolio

Asahi Kasei Corporate Venture Capital Overview

Investor Type

Venture Capital

Status

Active

Professionals

5

Investments

74

Portfolio

51

Exits

17

Asahi Kasei Corporate Venture Capital General Information

Company Description

Founded in 2008, Asahi Kasei Corporate Venture Capital is the venture capital arm of Asahi Kasei based in Menlo Park, California. The firm prefers to invest in materials, homes, and healthcare sector.

Business Details

Website

www.asahikaseiventures.com

Year Founded

2008

Investor Status

Actively Seeking New Investments

Primary Investor Type

Corporate Venture Capital

Corporate Office

4600 Bohannon Drive
Suite 220
Menlo Park, CA 94025
United States

+1 (650)

Asahi Kasei Corporate Venture Capital Investments (74)

Company Name	Deal Date	Deal Type	Industry	Company Stage
Glycomine	16-Apr-2025	Later Stage VC	Drug Discovery	Clinical Trials - Phase 2
Power to Hydrogen	19-Aug-2024		Energy Production	Generating Revenue
Kins (Clinics/Outpatient Services)	16-Jul-2024		Clinics/Outpatient Services	Generating Revenue
Syngoi	10-Jun-2024		Biotechnology	Generating Revenue
WealthPark	14-May-2024		Business/Productivity Software	Generating Revenue
Pulmocide	16-Apr-2024		Drug Discovery	Clinical Trials - Phase 3
Cyto-Facto	31-Mar-2024		Other Commercial Services	Generating Revenue
Noctrix Health	16-Jan-2024		Therapeutic Devices	Clinical Trials - Phase 2
Topsound Technology	03-Jan-2024	Early Stage VC	Machinery (B2B)	Startup
Avation Medical	15-Dec-2023	Later Stage VC	Therapeutic Devices	Generating Revenue

You’re viewing 10 of 74 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Asahi Kasei Corporate Venture Capital Exits (17)

Company Name	Exit Date	Exit Type
Curreio	09-Apr-2025	Bankruptcy: Liquidation
Tout Audio	27-Mar-2025
Humavox	01-Aug-2023
Mirexus	15-Feb-2023
Curonix	29-Oct-2022
Enerbee	02-Feb-2022
Rapid Micro Biosystems	15-Jul-2021
Respicardia	09-Apr-2021
Chrono Therapeutics	01-Feb-2021	Out of Business
Atox Bio	31-Dec-2019	Out of Business

You’re viewing 10 of 17 exits. Get the full list »

Asahi Kasei Corporate Venture Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.